Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Saniona AB ( (SE:SANION) ).
Saniona has appointed Johnny Stilou as Chief Financial Officer, bringing over 25 years of financial leadership experience to the company. His expertise in corporate finance and capital markets is expected to support Saniona’s financial strategy and investor relations as it advances its pipeline and seeks long-term financing solutions.
More about Saniona AB
Saniona is a clinical-stage biopharmaceutical company focused on developing treatments for neurological and psychiatric diseases. The company has an internal pipeline targeting epilepsy and major depressive disorder and engages in strategic collaborations for essential tremor and obesity treatments. Saniona is based in Copenhagen and is listed on Nasdaq Stockholm Main Market.
YTD Price Performance: -0.50%
Average Trading Volume: 645,679
Current Market Cap: SEK1.08B
See more data about SANION stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue